Clinical Trial Update: A Randomized Study to Evaluate a Novel Method of Specific Allergen Immunotherapy [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating a novel method of specific allergen immunotherapy for grass pollen-induced rhinoconjunctivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Allergic Rhinitis

Drugs mentioned

• Novel method of specific allergen immunotherapy

Snippet

Sponsor: University of Zurich | Conditions: Rhinoconjunctivitis Due to Grass Pollen Allergy | Phase 2 | Status: COMPLETED